Some CRMO patients have been shown to have pathogenic variants in the LPIN2 (Lipin 2), a protein coding gene that acts during normal adipose tissue development, playing a role in human triglyceride metabolism as a phosphatidate phosphatase enzyme, magnesium dependent. Here, LPIN2 is linked to chronic recurrent multifocal osteomyelitis.